Assessment of the reliability of MSI status and dMMR proteins deficiency screening on endoscopic biopsy material in esophagus and gastric adenocarcinoma

• Published in: Digestive and liver disease Vol. 55; no. 8; pp. 1105 - 1113
• Main Authors: Asesio, Nicolas, Mhamdi Aloui, Nozha, Bonnereau, Julie, Lehmann-Che, Jacqueline, Bouhidel, Fatiha, Kaci, Rachid, Corte, Hélène, Svrcek, Magali, Minh, My Linh Tran, Gornet, Jean Marc, Cattan, Pierre, Allez, Matthieu, Bertheau, Philippe, Aparicio, Thomas
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01-08-2023
• Subjects: Diagnosis; Endoscopic biopsy; Immunohistochemistry; Microsatellite instability; Oeso-gastric adenocarcinoma; Immunohistochemistry; Microsatellite instability; Diagnosis; Oeso-gastric adenocarcinoma; Endoscopic biopsy
• ISSN: 1590-8658; 1878-3562
• DOI: 10.1016/j.dld.2023.04.020

Microsatellite instability (MSI) is a negative predictive factor for neoadjuvant chemotherapy in resectable oesogastric adenocarcinoma and a crucial determinant for immunotherapy. We aimed to evaluate reliability of dMMR/MSI status screening performed on preoperative endoscopic biopsies.
Paired pathological samples from biopsies and surgical specimen of oesogastric adenocarcinoma were retrospectively collected between 2009 and 2019. We compared dMMR status obtained by immunohistochemistry (IHC) and MSI status by PCR. dMMR/MSI status on surgical specimen was considered as reference.
PCR and IHC were conclusive on biopsies respectively for 53 (96.4%) and 47 (85.5%) of the 55 patients enrolled. IHC was not contributive for 1 surgical specimen. A third reading of IHC was carried out for 3 biopsies. MSI status was observed in 7 (12.5%) surgical specimens. When analyses were contributive, sensitivity and specificity of biopsies for dMMR/MSI were respectively 85% and 98% for PCR vs. 86% and 98% for IHC. Concordance rate between biopsies and surgical specimen was 96.2% for PCR and 97.8% for IHC.
Endoscopic biopsies are a suitable source of tissue for dMMR/MSI status determination in oesogastric adenocarcinoma which should be routinely performed at diagnosis to better adapt neoadjuvant treatment.
By comparison of dMMR phenotype obtained by immunohistochemistry and MSI status by PCR between match-paired samples of oesogastric cancer's endoscopic biopsies and surgical specimen, we observed that biopsies are a suitable source of tissue for dMMR/MSI status determination.